These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 15389596)
1. TNF-alpha expression is transcriptionally regulated by RANK ligand. Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596 [TBL] [Abstract][Full Text] [Related]
2. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676 [TBL] [Abstract][Full Text] [Related]
3. Dual modulation of osteoclast differentiation by lipopolysaccharide. Zou W; Bar-Shavit Z J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109 [TBL] [Abstract][Full Text] [Related]
5. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627 [TBL] [Abstract][Full Text] [Related]
6. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680 [TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Wada N; Maeda H; Yoshimine Y; Akamine A Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598 [TBL] [Abstract][Full Text] [Related]
9. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells. Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411 [TBL] [Abstract][Full Text] [Related]
10. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833 [TBL] [Abstract][Full Text] [Related]
11. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha). Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717 [TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930 [TBL] [Abstract][Full Text] [Related]
15. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation. Ichikawa H; Murakami A; Aggarwal BB Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641 [TBL] [Abstract][Full Text] [Related]
16. In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer. Zhang J; Lu Y; Dai J; Yao Z; Kitazawa R; Kitazawa S; Zhao X; Hall DE; Pienta KJ; Keller ET Prostate; 2004 Jun; 59(4):360-9. PubMed ID: 15065084 [TBL] [Abstract][Full Text] [Related]
17. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis. Beranger GE; Momier D; Rochet N; Quincey D; Guigonis JM; Samson M; Carle GF; Scimeca JC J Bone Miner Res; 2006 Nov; 21(11):1757-69. PubMed ID: 17002555 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Kitazawa R; Kitazawa S Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948 [TBL] [Abstract][Full Text] [Related]
19. Propanil inhibits tumor necrosis factor-alpha production by reducing nuclear levels of the transcription factor nuclear factor-kappab in the macrophage cell line ic-21. Frost LL; Neeley YX; Schafer R; Gibson LF; Barnett JB Toxicol Appl Pharmacol; 2001 May; 172(3):186-93. PubMed ID: 11312646 [TBL] [Abstract][Full Text] [Related]
20. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]